Does TAFASITAMAB Cause Pneumonia? 66 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 66 reports of Pneumonia have been filed in association with TAFASITAMAB (MONJUVI). This represents 4.7% of all adverse event reports for TAFASITAMAB.
66
Reports of Pneumonia with TAFASITAMAB
4.7%
of all TAFASITAMAB reports
28
Deaths
45
Hospitalizations
How Dangerous Is Pneumonia From TAFASITAMAB?
Of the 66 reports, 28 (42.4%) resulted in death, 45 (68.2%) required hospitalization, and 11 (16.7%) were considered life-threatening.
Is Pneumonia Listed in the Official Label?
Yes, Pneumonia is listed as a known adverse reaction in the official FDA drug label for TAFASITAMAB.
What Other Side Effects Does TAFASITAMAB Cause?
Disease progression (470)
Diffuse large b-cell lymphoma (346)
Off label use (203)
Death (146)
Neutropenia (99)
Covid-19 (96)
General physical health deterioration (75)
Febrile neutropenia (64)
Drug ineffective (62)
Thrombocytopenia (60)
What Other Drugs Cause Pneumonia?
LENALIDOMIDE (14,807)
ADALIMUMAB (11,570)
RITUXIMAB (11,068)
METHOTREXATE (10,278)
PREDNISONE (8,472)
ETANERCEPT (8,225)
DEXAMETHASONE (6,073)
INFLIXIMAB (5,885)
POMALIDOMIDE (5,792)
TOCILIZUMAB (5,484)
Which TAFASITAMAB Alternatives Have Lower Pneumonia Risk?
TAFASITAMAB vs TAFASITAMAB-CXIX
TAFASITAMAB vs TAFINLAR
TAFASITAMAB vs TAFLUPROST
TAFASITAMAB vs TAGRAXOFUSP-ERZS
TAFASITAMAB vs TAHOR